Open-label, Prospective Study on the Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to assess the effects of Cetyl Tranexamate Mesylate on acne-related hyperpigmentation through a specific delivery form known as TeraCeutic TXVector.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 45
Healthy Volunteers: t
View:
• Males and females between the ages of 14 years of age until 55 years of age
• Individuals experiencing 3 different areas minimum of facial post-inflammatory hyperpigmentation in those with acne
Locations
United States
California
Integrative Skin and Research
Sacramento
Time Frame
Start Date: 2023-11-06
Completion Date: 2024-01-11
Participants
Target number of participants: 22
Treatments
Experimental: Topical Cetyl Tranexamate Mesylate
Product will be used on the face twice daily in the morning and in the evening for 2 weeks.
Related Therapeutic Areas
Sponsors
Leads: Integrative Skin Science and Research
Collaborators: Actera